These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 642629)

  • 41. A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.
    Barnardo DE; Lancaster-Smith M; Strickland ID; Wright JT
    Curr Med Res Opin; 1975; 3(6):388-91. PubMed ID: 1183220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
    Greally P; Hampton FJ; MacFadyen UM; Simpson H
    Arch Dis Child; 1992 May; 67(5):618-21. PubMed ID: 1599300
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
    Onuchina EV; Brikova SI; Tsukanov VV
    Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The suppression of gastro-oesophageal reflux by alginates.
    Dettmar PW; Hampson FC; Taubel J; Lorch U; Johnstone LM; Sykes J; Berry PJ
    Int J Clin Pract; 2007 Oct; 61(10):1654-62. PubMed ID: 17681004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The alginate raft: a scintigraphic evaluation.
    McKay AP; Wraight EP; Hunter JO
    Br J Clin Pract Suppl; 1989 Feb; 66():20-4; discussion 35-6. PubMed ID: 2511919
    [No Abstract]   [Full Text] [Related]  

  • 47. A comparison of gastro-oesophageal reflux in volunteers assessed by ambulatory pH and gamma monitoring after treatment with either Liquid Gaviscon or Algicon Suspension.
    Washington N; Greaves JL; Iftikhar SY
    Aliment Pharmacol Ther; 1992 Oct; 6(5):579-88. PubMed ID: 1420749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oesophageal disease in the elderly.
    Pelemans W; Vantrappen G
    Clin Gastroenterol; 1985 Oct; 14(4):635-56. PubMed ID: 2867841
    [No Abstract]   [Full Text] [Related]  

  • 49. Reflux esophagitis treated with Gaviscon.
    Amdrup E; Jakobsen BM
    Acta Chir Scand Suppl; 1969; 396():16-7. PubMed ID: 5257679
    [No Abstract]   [Full Text] [Related]  

  • 50. Patterns of food and acid reflux in patients with low-grade oesophagitis--the role of an anti-reflux agent.
    Washington N; Steele RJ; Jackson SJ; Washington C; Bush D
    Aliment Pharmacol Ther; 1998 Jan; 12(1):53-8. PubMed ID: 9692701
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
    Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
    Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
    [No Abstract]   [Full Text] [Related]  

  • 52. [Esophageal reflux and peptic ulcer. An exclusive advanced education service of the Gastro-Liga for family physicians].
    Fortschr Med; 1998 Dec; 116(34):35-8. PubMed ID: 10024760
    [No Abstract]   [Full Text] [Related]  

  • 53. [Alginates in the treatment of postgastroresection reflux esophagitis].
    Ianova OB; Kim VA; Treĭman EV
    Ter Arkh; 2012; 84(10):48-50. PubMed ID: 23227500
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gaviscon and domperidon responsive apnea episodes associated with gastro-esophageal reflux disease in twins.
    Bilgin H; Eren A; Kara S
    Asia Pac J Clin Nutr; 2015; 24(4):753-5. PubMed ID: 26693761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
    Buts JP; Barudi C; Otte JB
    Eur J Pediatr; 1987 Mar; 146(2):156-8. PubMed ID: 3032640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
    Smart HL; Atkinson M
    J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
    Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
    Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
    [No Abstract]   [Full Text] [Related]  

  • 59. [Magnesium hydroxide and aluminum hydroxide in the treatment of gastroesophageal reflux].
    Iacono G; Carroccio A; Montalto G; Cavataio F; Ippolito S; Kazmierska I; Balsamo V
    Minerva Pediatr; 1991 Dec; 43(12):797-800. PubMed ID: 1798406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Can acid pocket-targeting alginate-antacid (Gaviscon Double Action) relieve upper gastrointestinal symptoms in gastro-oesophageal reflux disease?].
    Kim SE; Park MI
    Korean J Gastroenterol; 2014 Jun; 63(6):386-8. PubMed ID: 25097964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.